SEALSQ's Q4 2025 Earnings Call Reveals Audited Results but Highlights Ongoing Execution Risks

What happened

SEALSQ conducted its Q4 2025 earnings call, confirming audited FY2025 revenue of $18 million, which aligns with preliminary unaudited figures but requires careful scrutiny due to past discrepancies in financial reporting. The audited statements reconciled cash balances, showing an increase to over $425 million from $84.6 million in prior filings, though this jump raises questions about funding sources and liquidity sustainability. Management attributed the revenue growth primarily to legacy products and the IC'ALPS acquisition, with post-quantum cryptography (PQC) offerings like QS7001 and QVault-TPM still contributing minimally and facing timeline uncertainties, including TPM sampling set for November 2026. Customer concentration remains a critical vulnerability, with one client accounting for 36% of FY2024 sales, exacerbating volatility amid the transition to next-gen products. The company reiterated aggressive FY2026 growth guidance of 50-100%, but this hinges on converting a reported $200 million+ pipeline into firm orders, a process yet to be substantiated in filings.

Implication

The earnings call underscores that SEALSQ's investment case remains unproven, as audited results, while provided, do not fully resolve risks like cash reconciliation or PQC monetization delays. Investors must monitor Q1-Q2 2026 revenue for signs of PQC contribution, not just legacy growth, to validate the 50-100% FY2026 target. Dilution risks from VWAP-linked convertibles persist, especially if stock price weakness triggers unfavorable conversion terms, potentially eroding per-share value even if revenue improves. High customer concentration and lack of long-term contracts mean revenue stability is fragile, requiring close watch on order books and pipeline conversion in filings. A 'wait-and-see' approach is prudent until clearer evidence of production awards and certification milestones emerges, aligning with the DeepValue report's WAIT rating.

Thesis delta

The earnings call delivers the audited FY2025 results that were a key catalyst, shifting the investment thesis from awaiting verification to assessing execution on pipeline conversion and revenue mix. However, no material shift in the core thesis occurs, as risks around TPM timing, cash consistency, and dilution remain unresolved, reinforcing the need for continued monitoring over the next 3-6 months without immediate position adjustments.